Across TCGA pan-cancer cohorts, TUBA3E RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated TUBA3E data layer compared with 5 for mutation status.
The strongest signal is observed in breast invasive carcinoma (BRCA), where higher TUBA3E RNA is associated with better overall survival. In most high-consensus cancer types, elevated TUBA3E expression acts as an unfavorable survival marker, although some lineages such as BRCA and UCEC show a favorable association.
BRCA, UCEC, and THCA are the cancer types where TUBA3E RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.